Pharmaceuticals, Biotechnology and Life Sciences
– Antigen component of IVX-411 found to be unstable; issue specific to molecule, with no evidence of read-through to other…
BOSTON, July 28, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that it…
WOODCLIFF LAKE, N.J., July 28, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced…
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PTBURLINGAME, Calif., July 28, 2022 (GLOBE…
REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel…
PORTLAND, Maine, July 27, 2022 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021…
Company to Move Forward with Key U.S. Regulatory Applications – Investigational New Drug and Orphan Drug DesignationBOSTON, July 26, 2022…
HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second…
— Preclinical model data expected to support development of small diameter HAV to treat patients with coronary artery disease– —…